ClinicalTrials.gov
ClinicalTrials.gov Menu

Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00002775
Recruitment Status : Unknown
Verified April 2000 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
First Posted : September 2, 2004
Last Update Posted : January 6, 2014
Sponsor:
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given